A year and a half after John Menard ousted Steve and Tomisue Hilbert as the managers of the private equity firm they all started, attorneys for the two sides continue to fight bitterly for every tactical advantage in a dozen lawsuits between them.
As local hospitals try to offer package deals with upfront prices on joint replacement surgeries, they're struggling with the reality that patients' other health conditions can significantly increase their cost of care.
Community executives said the investment and projects, which will begin this fall and extend over several years, prove their long-term commitment to the east side of the city.
A new study finds that Obamacare boosted enrollment in Indiana’s individual insurance market significantly over what it would have been without the law, but also caused premiums to spike.
Lilly is finally putting meat on the bones of its predictions about its experimental diabetes and cancer drugs. That gives investors the certainty they crave that Lilly’s future revenue won’t remain in its 2014 doldrums.
Rattled by new state teacher ratings, the colleges hope to avoid black eyes, themselves.
Conservatives, after waging war on Obamacare, including its large expansion of Medicaid, are starting to try to propose alternative, conservative ways to achieve its key goals.
Companion Diagnostics Inc., a biotech company that relocated to Indiana from Connecticut in 2010, has entered bankruptcy reorganization while it tries to develop a therapy for inflammation.
When Hoosiers start shopping on the Obamacare exchanges again in November, they’ll find new, lower-priced competitors and modest price increases that are much lower than insurers initially proposed. But that doesn’t mean they’ll save money.
Indiana does not appear to be enjoying the rest of the nation’s slowdown in health care spending. Year-to-year growth in Indiana hit 6 percent in 2012 versus 4.5 percent for the nation.
The endowment hopes to expand educational MBA programs, including one at the University of Indianapolis, to give business skills to more principals and superintendents at Indiana public schools.
Just three months before the parent company of AIT Laboratories was sold in 2009 to its employees for $90 million, it was appraised for $17.1 million, according to a U.S. Department of Labor lawsuit.
The Indiana Blood Center is set to lose more than one-third of its revenue early next year, as three hospital systems bolt for cheaper prices offered by the American Red Cross.
Indiana has 58 percent more nursing homes per resident and spends an extra $1 billion per year on care in nursing homes than the average for the rest of the country.
Anthem patients in five U.S. cities, including Indianapolis, spent $220 less per MRI scan after Anthem told them of lower-cost facilities. In response, hospital-owned MRI facilities cut their prices.
Franciscan Alliance, which operates three hospitals in the Indianapolis area, is seeing fewer patients this year but is making more money due to expense cuts.
Mainstreet Property Group, already the fastest-growing company in the Indianapolis area, now has the fuel it needs to nearly triple its pace of construction of senior care facilities around the country.
The Flanner House Elementary charter school will close on Sept. 11 after the Indiana Department of Education found evidence of widespread cheating on the state standardized ISTEP test. The school has 176 students.
The drug company said Thursday its drug ixekizumab cleared away skin inflammation in six times as many patients as the blockbuster drug Enbrel. Lilly is in a race to bring the first in a new-class of psoriasis treatments to market.
State and local governments hand out $921 million per year to entice business to add jobs. The Medicaid expansion is estimated to cost no more than $279 million per year.
